

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cardiac myofibril assembly (GO:0055003) | 4.43013643 |
| 2 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.36916887 |
| 3 | plasma membrane repair (GO:0001778) | 4.19945388 |
| 4 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.15215175 |
| 5 | lymph vessel development (GO:0001945) | 4.10257306 |
| 6 | sarcomere organization (GO:0045214) | 4.06989855 |
| 7 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.98248409 |
| 8 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.89227111 |
| 9 | vascular endothelial growth factor signaling pathway (GO:0038084) | 3.87137211 |
| 10 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.86091528 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.84862055 |
| 12 | myofibril assembly (GO:0030239) | 3.72513602 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.62033002 |
| 14 | glomerular basement membrane development (GO:0032836) | 3.61060690 |
| 15 | surfactant homeostasis (GO:0043129) | 3.50807802 |
| 16 | regulation of actin filament-based movement (GO:1903115) | 3.49827021 |
| 17 | cell communication by electrical coupling (GO:0010644) | 3.44739642 |
| 18 | heart trabecula formation (GO:0060347) | 3.43664625 |
| 19 | cardiac muscle contraction (GO:0060048) | 3.38637135 |
| 20 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.24301023 |
| 21 | regulation of membrane repolarization (GO:0060306) | 3.21729748 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.20717756 |
| 23 | cell communication involved in cardiac conduction (GO:0086065) | 3.19132619 |
| 24 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.18077721 |
| 25 | relaxation of cardiac muscle (GO:0055119) | 3.14965621 |
| 26 | regulation of the force of heart contraction (GO:0002026) | 3.08693533 |
| 27 | regulation of cell communication by electrical coupling (GO:0010649) | 3.07785946 |
| 28 | regulation of relaxation of muscle (GO:1901077) | 3.05091837 |
| 29 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.04145682 |
| 30 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 3.03343251 |
| 31 | regulation of sarcomere organization (GO:0060297) | 3.03131668 |
| 32 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 3.02704267 |
| 33 | chemical homeostasis within a tissue (GO:0048875) | 3.02291745 |
| 34 | detection of calcium ion (GO:0005513) | 2.99273752 |
| 35 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.96805103 |
| 36 | actomyosin structure organization (GO:0031032) | 2.93287941 |
| 37 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.91013391 |
| 38 | cell adhesion mediated by integrin (GO:0033627) | 2.90811530 |
| 39 | lymphangiogenesis (GO:0001946) | 2.90660915 |
| 40 | basement membrane organization (GO:0071711) | 2.87220750 |
| 41 | endothelium development (GO:0003158) | 2.86868834 |
| 42 | potassium ion import (GO:0010107) | 2.86253941 |
| 43 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.84986327 |
| 44 | regulation of striated muscle contraction (GO:0006942) | 2.80311692 |
| 45 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 2.79952095 |
| 46 | collagen fibril organization (GO:0030199) | 2.79786512 |
| 47 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.79037901 |
| 48 | blood vessel maturation (GO:0001955) | 2.78696031 |
| 49 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.78611672 |
| 50 | endodermal cell differentiation (GO:0035987) | 2.77867542 |
| 51 | muscle filament sliding (GO:0030049) | 2.76880967 |
| 52 | actin-myosin filament sliding (GO:0033275) | 2.76880967 |
| 53 | cardiac muscle hypertrophy (GO:0003300) | 2.74476205 |
| 54 | adult heart development (GO:0007512) | 2.74107083 |
| 55 | activation of protein kinase A activity (GO:0034199) | 2.73046244 |
| 56 | regulation of cardiac muscle contraction (GO:0055117) | 2.72456559 |
| 57 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 2.68687431 |
| 58 | tricarboxylic acid cycle (GO:0006099) | 2.65342013 |
| 59 | cardiac muscle cell development (GO:0055013) | 2.65295067 |
| 60 | striated muscle hypertrophy (GO:0014897) | 2.63738126 |
| 61 | negative regulation of protein localization to cell surface (GO:2000009) | 2.61733723 |
| 62 | peripheral nervous system axon ensheathment (GO:0032292) | 2.61258389 |
| 63 | myelination in peripheral nervous system (GO:0022011) | 2.61258389 |
| 64 | carnitine shuttle (GO:0006853) | 2.61018186 |
| 65 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.60518120 |
| 66 | cell migration involved in heart development (GO:0060973) | 2.60514821 |
| 67 | negative regulation of potassium ion transport (GO:0043267) | 2.59706082 |
| 68 | negative regulation of Rho protein signal transduction (GO:0035024) | 2.59525359 |
| 69 | regulation of skeletal muscle contraction (GO:0014819) | 2.59424007 |
| 70 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.58096887 |
| 71 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.57769964 |
| 72 | positive regulation of vasculogenesis (GO:2001214) | 2.56092677 |
| 73 | regulation of cardioblast differentiation (GO:0051890) | 2.55995879 |
| 74 | cardiac conduction (GO:0061337) | 2.55013129 |
| 75 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.54129225 |
| 76 | fatty acid transmembrane transport (GO:1902001) | 2.54019802 |
| 77 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.53552843 |
| 78 | cardiac cell development (GO:0055006) | 2.53165595 |
| 79 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.53084388 |
| 80 | regulation of synapse structural plasticity (GO:0051823) | 2.52169212 |
| 81 | regulation of vasculogenesis (GO:2001212) | 2.52145078 |
| 82 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.51832451 |
| 83 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.51832451 |
| 84 | cell migration involved in sprouting angiogenesis (GO:0002042) | 2.51830424 |
| 85 | coronary vasculature morphogenesis (GO:0060977) | 2.51729410 |
| 86 | protein heterotrimerization (GO:0070208) | 2.51397313 |
| 87 | cell-substrate junction assembly (GO:0007044) | 2.50517732 |
| 88 | regulation of p38MAPK cascade (GO:1900744) | 2.48744359 |
| 89 | positive regulation of cation channel activity (GO:2001259) | 2.47582810 |
| 90 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.47255195 |
| 91 | cardiac muscle cell action potential (GO:0086001) | 2.47225704 |
| 92 | striated muscle contraction (GO:0006941) | 2.46834425 |
| 93 | protein localization to cell surface (GO:0034394) | 2.46456939 |
| 94 | metanephric nephron epithelium development (GO:0072243) | 2.46066735 |
| 95 | metanephric nephron tubule development (GO:0072234) | 2.45857829 |
| 96 | metanephric tubule development (GO:0072170) | 2.45857829 |
| 97 | regulation of heart rate (GO:0002027) | 2.45579708 |
| 98 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.44502447 |
| 99 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.44117285 |
| 100 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.43882359 |
| 101 | glomerular filtration (GO:0003094) | 2.43221502 |
| 102 | endothelial cell morphogenesis (GO:0001886) | 2.41847848 |
| 103 | actin-mediated cell contraction (GO:0070252) | 2.41235617 |
| 104 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.41121038 |
| 105 | regulation of heart contraction (GO:0008016) | 2.39966057 |
| 106 | skin morphogenesis (GO:0043589) | 2.39834943 |
| 107 | trabecula formation (GO:0060343) | 2.39562150 |
| 108 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.39476191 |
| 109 | muscle tissue morphogenesis (GO:0060415) | 2.37978883 |
| 110 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.36410106 |
| 111 | neuron projection extension involved in neuron projection guidance (GO:1902284) | 2.35998219 |
| 112 | axon extension involved in axon guidance (GO:0048846) | 2.35998219 |
| 113 | establishment of nucleus localization (GO:0040023) | 2.34800122 |
| 114 | layer formation in cerebral cortex (GO:0021819) | 2.34425102 |
| 115 | positive regulation of heart rate (GO:0010460) | 2.34051580 |
| 116 | embryonic heart tube development (GO:0035050) | 2.33570229 |
| 117 | venous blood vessel morphogenesis (GO:0048845) | 2.33537796 |
| 118 | renal filtration (GO:0097205) | 2.33061968 |
| 119 | actin filament-based movement (GO:0030048) | 2.32856357 |
| 120 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.32703677 |
| 121 | positive regulation of heart contraction (GO:0045823) | 2.32347792 |
| 122 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.31974384 |
| 123 | chondrocyte proliferation (GO:0035988) | 2.31466706 |
| 124 | collagen metabolic process (GO:0032963) | 2.30574794 |
| 125 | adherens junction assembly (GO:0034333) | 2.30567905 |
| 126 | succinate metabolic process (GO:0006105) | 2.30120216 |
| 127 | sodium ion export (GO:0071436) | 2.29913522 |
| 128 | protein targeting to Golgi (GO:0000042) | 2.29433760 |
| 129 | vocalization behavior (GO:0071625) | 2.29352485 |
| 130 | metanephric epithelium development (GO:0072207) | 2.27099648 |
| 131 | cell-substrate adherens junction assembly (GO:0007045) | 2.25930819 |
| 132 | focal adhesion assembly (GO:0048041) | 2.25930819 |
| 133 | substrate-dependent cell migration (GO:0006929) | 2.25787761 |
| 134 | negative regulation of fatty acid transport (GO:2000192) | 2.24555616 |
| 135 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.24351869 |
| 136 | cellular response to epinephrine stimulus (GO:0071872) | 2.23217151 |
| 137 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.23018054 |
| 138 | extracellular matrix assembly (GO:0085029) | 2.22356035 |
| 139 | response to epinephrine (GO:0071871) | 2.21490187 |
| 140 | collagen catabolic process (GO:0030574) | 2.21002477 |
| 141 | endocrine hormone secretion (GO:0060986) | 2.20746006 |
| 142 | negative regulation of vascular permeability (GO:0043116) | 2.20738792 |
| 143 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.19457853 |
| 144 | paraxial mesoderm development (GO:0048339) | 2.19022074 |
| 145 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.18703229 |
| 146 | regulation of lipoprotein metabolic process (GO:0050746) | 2.18523938 |
| 147 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.18139516 |
| 148 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.14027173 |
| 149 | multicellular organismal metabolic process (GO:0044236) | 2.13069766 |
| 150 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.12729005 |
| 151 | endocardial cushion development (GO:0003197) | 2.12432059 |
| 152 | extracellular fibril organization (GO:0043206) | 2.12356160 |
| 153 | positive regulation of osteoblast proliferation (GO:0033690) | 2.11824913 |
| 154 | regulation of axon extension involved in axon guidance (GO:0048841) | 2.11182793 |
| 155 | muscle hypertrophy (GO:0014896) | 2.10294753 |
| 156 | positive regulation of muscle hypertrophy (GO:0014742) | 2.09634897 |
| 157 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.09634897 |
| 158 | apoptotic cell clearance (GO:0043277) | 2.07423408 |
| 159 | extracellular matrix disassembly (GO:0022617) | 2.07394894 |
| 160 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.07043389 |
| 161 | smooth muscle tissue development (GO:0048745) | 2.05983582 |
| 162 | camera-type eye morphogenesis (GO:0048593) | 2.05687880 |
| 163 | macroautophagy (GO:0016236) | 2.04098807 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.47283789 |
| 2 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.62910215 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.55048173 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.39747063 |
| 5 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.22616994 |
| 6 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.19753869 |
| 7 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.17235216 |
| 8 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.12895500 |
| 9 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.12895500 |
| 10 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.09582286 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.97994335 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.94701841 |
| 13 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.92522164 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.91481806 |
| 15 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.91260829 |
| 16 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.90067777 |
| 17 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.87144527 |
| 18 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.86728524 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74847389 |
| 20 | * EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.74357706 |
| 21 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.73317092 |
| 22 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.72151429 |
| 23 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.66954711 |
| 24 | * EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.65925638 |
| 25 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.65694288 |
| 26 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.65694288 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.59912187 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.57334639 |
| 29 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.55833019 |
| 30 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.52615164 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.52005488 |
| 32 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51693833 |
| 33 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.47228662 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.47108025 |
| 35 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.46460016 |
| 36 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.40890501 |
| 37 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.40838593 |
| 38 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39858554 |
| 39 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.38211991 |
| 40 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.35419524 |
| 41 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.34831921 |
| 42 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.34428728 |
| 43 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.30983581 |
| 44 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30835211 |
| 45 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.30084444 |
| 46 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.29885556 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.29548084 |
| 48 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.29533684 |
| 49 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.29189165 |
| 50 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.28805058 |
| 51 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27249237 |
| 52 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.26940399 |
| 53 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.26855013 |
| 54 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26315392 |
| 55 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.25139821 |
| 56 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.25030949 |
| 57 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.22728231 |
| 58 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.22596988 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.22282443 |
| 60 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22265585 |
| 61 | CJUN_26792858_Chip-Seq_BT549_Human | 1.21693988 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.21502315 |
| 63 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.21450007 |
| 64 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.20938291 |
| 65 | * HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.19786124 |
| 66 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.19346376 |
| 67 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.19325439 |
| 68 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.17510198 |
| 69 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16250562 |
| 70 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.15959005 |
| 71 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.15575107 |
| 72 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.14493869 |
| 73 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.12883654 |
| 74 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.12468350 |
| 75 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.11437692 |
| 76 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.10158854 |
| 77 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10094440 |
| 78 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10094440 |
| 79 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.08946462 |
| 80 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.08640374 |
| 81 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.08503036 |
| 82 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07953919 |
| 83 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07732332 |
| 84 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07206855 |
| 85 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.07206827 |
| 86 | KDM2B_26808549_Chip-Seq_K562_Human | 1.06801453 |
| 87 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.06710290 |
| 88 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.05143127 |
| 89 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.04857510 |
| 90 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.04122458 |
| 91 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.03696566 |
| 92 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.03223915 |
| 93 | * TP53_16413492_ChIP-PET_HCT116_Human | 1.03208164 |
| 94 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02957508 |
| 95 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.00516151 |
| 96 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.00499981 |
| 97 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00241545 |
| 98 | * AR_19668381_ChIP-Seq_PC3_Human | 0.99355199 |
| 99 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99169689 |
| 100 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99022307 |
| 101 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 0.98861704 |
| 102 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 0.98478849 |
| 103 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97690103 |
| 104 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.97256456 |
| 105 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97243216 |
| 106 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.97115133 |
| 107 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.96639672 |
| 108 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.96619063 |
| 109 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.95584478 |
| 110 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.95561912 |
| 111 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.94599105 |
| 112 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.94339489 |
| 113 | AR_25329375_ChIP-Seq_VCAP_Human | 0.94146916 |
| 114 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.92840535 |
| 115 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92736063 |
| 116 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.92194332 |
| 117 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.91360598 |
| 118 | * MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.91270872 |
| 119 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.90882788 |
| 120 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90530499 |
| 121 | GATA1_22025678_ChIP-Seq_K562_Human | 0.90325988 |
| 122 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.90217816 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.61640483 |
| 2 | MP0004084_abnormal_cardiac_muscle | 4.30228868 |
| 3 | MP0004215_abnormal_myocardial_fiber | 3.67105023 |
| 4 | MP0000751_myopathy | 3.66999820 |
| 5 | MP0010368_abnormal_lymphatic_system | 3.28268551 |
| 6 | MP0004036_abnormal_muscle_relaxation | 3.02172857 |
| 7 | MP0004272_abnormal_basement_membrane | 2.96041263 |
| 8 | MP0005257_abnormal_intraocular_pressure | 2.85449199 |
| 9 | MP0003646_muscle_fatigue | 2.75576140 |
| 10 | MP0001879_abnormal_lymphatic_vessel | 2.75237103 |
| 11 | MP0005167_abnormal_blood-brain_barrier | 2.57777600 |
| 12 | MP0006138_congestive_heart_failure | 2.52007451 |
| 13 | MP0005330_cardiomyopathy | 2.46003817 |
| 14 | MP0004484_altered_response_of | 2.43873415 |
| 15 | MP0002972_abnormal_cardiac_muscle | 2.34102030 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.17796702 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.15529177 |
| 18 | MP0000749_muscle_degeneration | 2.10874548 |
| 19 | MP0004130_abnormal_muscle_cell | 2.10092821 |
| 20 | MP0005171_absent_coat_pigmentation | 2.08448069 |
| 21 | MP0005623_abnormal_meninges_morphology | 2.08104883 |
| 22 | MP0005620_abnormal_muscle_contractility | 2.05264670 |
| 23 | MP0000013_abnormal_adipose_tissue | 2.02184947 |
| 24 | MP0004087_abnormal_muscle_fiber | 1.99618725 |
| 25 | MP0008438_abnormal_cutaneous_collagen | 1.98855608 |
| 26 | MP0003828_pulmonary_edema | 1.94638692 |
| 27 | MP0004085_abnormal_heartbeat | 1.92130165 |
| 28 | MP0001544_abnormal_cardiovascular_syste | 1.91997362 |
| 29 | MP0005385_cardiovascular_system_phenoty | 1.91997362 |
| 30 | MP0003137_abnormal_impulse_conducting | 1.85301787 |
| 31 | MP0004145_abnormal_muscle_electrophysio | 1.82905013 |
| 32 | MP0003279_aneurysm | 1.81303826 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.76120272 |
| 34 | MP0001958_emphysema | 1.70832565 |
| 35 | MP0005670_abnormal_white_adipose | 1.65547923 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.64108731 |
| 37 | MP0005409_darkened_coat_color | 1.52132390 |
| 38 | MP0003705_abnormal_hypodermis_morpholog | 1.44810048 |
| 39 | MP0002106_abnormal_muscle_physiology | 1.44458156 |
| 40 | MP0003045_fibrosis | 1.35264657 |
| 41 | MP0005369_muscle_phenotype | 1.34350950 |
| 42 | MP0004859_abnormal_synaptic_plasticity | 1.29874274 |
| 43 | MP0005666_abnormal_adipose_tissue | 1.27540099 |
| 44 | MP0002332_abnormal_exercise_endurance | 1.27506811 |
| 45 | MP0002127_abnormal_cardiovascular_syste | 1.27340446 |
| 46 | MP0010030_abnormal_orbit_morphology | 1.26769924 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.26166371 |
| 48 | MP0002295_abnormal_pulmonary_circulatio | 1.25371958 |
| 49 | MP0000759_abnormal_skeletal_muscle | 1.24427899 |
| 50 | MP0002108_abnormal_muscle_morphology | 1.24230973 |
| 51 | MP0000003_abnormal_adipose_tissue | 1.20616057 |
| 52 | MP0005165_increased_susceptibility_to | 1.20583141 |
| 53 | MP0003950_abnormal_plasma_membrane | 1.20055523 |
| 54 | MP0004233_abnormal_muscle_weight | 1.19735806 |
| 55 | MP0005375_adipose_tissue_phenotype | 1.16281387 |
| 56 | MP0000747_muscle_weakness | 1.13897615 |
| 57 | MP0005023_abnormal_wound_healing | 1.12826755 |
| 58 | MP0002269_muscular_atrophy | 1.12460293 |
| 59 | MP0009384_cardiac_valve_regurgitation | 1.10082232 |
| 60 | MP0005275_abnormal_skin_tensile | 1.09129895 |
| 61 | MP0009046_muscle_twitch | 1.09110186 |
| 62 | MP0005508_abnormal_skeleton_morphology | 1.08746933 |
| 63 | MP0000767_abnormal_smooth_muscle | 1.08134392 |
| 64 | MP0000534_abnormal_ureter_morphology | 1.07054027 |
| 65 | MP0003635_abnormal_synaptic_transmissio | 1.06784992 |
| 66 | MP0003122_maternal_imprinting | 1.06564162 |
| 67 | MP0001661_extended_life_span | 1.05233729 |
| 68 | MP0002971_abnormal_brown_adipose | 1.02594537 |
| 69 | MP0005503_abnormal_tendon_morphology | 1.00928464 |
| 70 | MP0004185_abnormal_adipocyte_glucose | 1.00132884 |
| 71 | MP0004510_myositis | 0.96449714 |
| 72 | MP0003941_abnormal_skin_development | 0.96328837 |
| 73 | MP0009250_abnormal_appendicular_skeleto | 0.94905603 |
| 74 | MP0002128_abnormal_blood_circulation | 0.93919479 |
| 75 | MP0003566_abnormal_cell_adhesion | 0.93847495 |
| 76 | * MP0005595_abnormal_vascular_smooth | 0.93064105 |
| 77 | MP0000266_abnormal_heart_morphology | 0.90543396 |
| 78 | MP0000230_abnormal_systemic_arterial | 0.88456979 |
| 79 | MP0003879_abnormal_hair_cell | 0.88000193 |
| 80 | MP0009840_abnormal_foam_cell | 0.87148264 |
| 81 | MP0001915_intracranial_hemorrhage | 0.85743073 |
| 82 | MP0002877_abnormal_melanocyte_morpholog | 0.83473175 |
| 83 | MP0003091_abnormal_cell_migration | 0.81797839 |
| 84 | MP0000733_abnormal_muscle_development | 0.80633459 |
| 85 | MP0002133_abnormal_respiratory_system | 0.80249572 |
| 86 | MP0005388_respiratory_system_phenotype | 0.80249572 |
| 87 | MP0001542_abnormal_bone_strength | 0.80238575 |
| 88 | MP0000343_altered_response_to | 0.79851344 |
| 89 | MP0002925_abnormal_cardiovascular_devel | 0.79174086 |
| 90 | MP0008961_abnormal_basal_metabolism | 0.78836070 |
| 91 | MP0004147_increased_porphyrin_level | 0.78012098 |
| 92 | MP0000762_abnormal_tongue_morphology | 0.77399302 |
| 93 | MP0001299_abnormal_eye_distance/ | 0.75442211 |
| 94 | MP0005164_abnormal_response_to | 0.75359902 |
| 95 | MP0002060_abnormal_skin_morphology | 0.75298185 |
| 96 | MP0005248_abnormal_Harderian_gland | 0.75245514 |
| 97 | MP0005187_abnormal_penis_morphology | 0.75150036 |
| 98 | MP0006054_spinal_hemorrhage | 0.74793830 |
| 99 | MP0000372_irregular_coat_pigmentation | 0.72960338 |
| 100 | MP0000163_abnormal_cartilage_morphology | 0.72201313 |
| 101 | MP0002064_seizures | 0.72151030 |
| 102 | MP0003942_abnormal_urinary_system | 0.71594249 |
| 103 | MP0002896_abnormal_bone_mineralization | 0.70989565 |
| 104 | MP0003283_abnormal_digestive_organ | 0.70555340 |
| 105 | MP0009745_abnormal_behavioral_response | 0.68504831 |
| 106 | MP0002876_abnormal_thyroid_physiology | 0.66490209 |
| 107 | MP0002168_other_aberrant_phenotype | 0.66197092 |
| 108 | MP0008569_lethality_at_weaning | 0.65956219 |
| 109 | MP0004858_abnormal_nervous_system | 0.65808583 |
| 110 | MP0004270_analgesia | 0.65254400 |
| 111 | MP0003329_amyloid_beta_deposits | 0.64839172 |
| 112 | MP0001486_abnormal_startle_reflex | 0.64690302 |
| 113 | MP0002115_abnormal_skeleton_extremities | 0.64148886 |
| 114 | MP0001614_abnormal_blood_vessel | 0.63561073 |
| 115 | MP0004924_abnormal_behavior | 0.63540430 |
| 116 | MP0005386_behavior/neurological_phenoty | 0.63540430 |
| 117 | MP0000462_abnormal_digestive_system | 0.62911839 |
| 118 | MP0002063_abnormal_learning/memory/cond | 0.60105361 |
| 119 | MP0003633_abnormal_nervous_system | 0.58595523 |
| 120 | MP0002272_abnormal_nervous_system | 0.58264952 |
| 121 | MP0002234_abnormal_pharynx_morphology | 0.58255402 |
| 122 | MP0000249_abnormal_blood_vessel | 0.58040966 |
| 123 | MP0001177_atelectasis | 0.57328494 |
| 124 | MP0004043_abnormal_pH_regulation | 0.57286129 |
| 125 | MP0003385_abnormal_body_wall | 0.55323584 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 5.70175235 |
| 2 | Atrial fibrillation (HP:0005110) | 4.60298224 |
| 3 | Muscle fiber splitting (HP:0003555) | 4.58185305 |
| 4 | Ventricular tachycardia (HP:0004756) | 4.30940700 |
| 5 | Primary atrial arrhythmia (HP:0001692) | 4.29510886 |
| 6 | Supraventricular arrhythmia (HP:0005115) | 4.13382193 |
| 7 | Hyporeflexia of lower limbs (HP:0002600) | 4.04755008 |
| 8 | Supraventricular tachycardia (HP:0004755) | 4.04515505 |
| 9 | Calf muscle hypertrophy (HP:0008981) | 4.01841654 |
| 10 | Exercise-induced muscle cramps (HP:0003710) | 3.84244926 |
| 11 | Exercise-induced myalgia (HP:0003738) | 3.81613260 |
| 12 | Broad metatarsal (HP:0001783) | 3.80353565 |
| 13 | Prolonged QT interval (HP:0001657) | 3.76310896 |
| 14 | Abnormality of the calf musculature (HP:0001430) | 3.72870671 |
| 15 | Syncope (HP:0001279) | 3.67049714 |
| 16 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.65189457 |
| 17 | Lipoatrophy (HP:0100578) | 3.53203153 |
| 18 | Bundle branch block (HP:0011710) | 3.47432737 |
| 19 | Difficulty running (HP:0009046) | 3.47043094 |
| 20 | Right ventricular cardiomyopathy (HP:0011663) | 3.39629557 |
| 21 | Increased connective tissue (HP:0009025) | 3.38114031 |
| 22 | Cerebral aneurysm (HP:0004944) | 3.22506527 |
| 23 | Asymmetric septal hypertrophy (HP:0001670) | 3.10823615 |
| 24 | Increased variability in muscle fiber diameter (HP:0003557) | 3.08196039 |
| 25 | Myotonia (HP:0002486) | 3.04618758 |
| 26 | Wormian bones (HP:0002645) | 3.03446567 |
| 27 | Ventricular fibrillation (HP:0001663) | 2.99487258 |
| 28 | EMG: myopathic abnormalities (HP:0003458) | 2.96466158 |
| 29 | Subaortic stenosis (HP:0001682) | 2.93974955 |
| 30 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.93974955 |
| 31 | Ventricular arrhythmia (HP:0004308) | 2.90111561 |
| 32 | Myoglobinuria (HP:0002913) | 2.85043764 |
| 33 | Dilated cardiomyopathy (HP:0001644) | 2.79678334 |
| 34 | Soft skin (HP:0000977) | 2.76046750 |
| 35 | Neonatal short-limb short stature (HP:0008921) | 2.72651066 |
| 36 | Heart block (HP:0012722) | 2.71630414 |
| 37 | Abnormal EKG (HP:0003115) | 2.67101676 |
| 38 | Atrioventricular block (HP:0001678) | 2.62413895 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.61288860 |
| 40 | Abnormal atrioventricular conduction (HP:0005150) | 2.58699844 |
| 41 | Palpitations (HP:0001962) | 2.55226625 |
| 42 | Hypoplastic ischia (HP:0003175) | 2.54470304 |
| 43 | Polycythemia (HP:0001901) | 2.51875354 |
| 44 | Mitral stenosis (HP:0001718) | 2.51174637 |
| 45 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.50968997 |
| 46 | Muscle fiber inclusion bodies (HP:0100299) | 2.45912330 |
| 47 | Difficulty climbing stairs (HP:0003551) | 2.43114075 |
| 48 | Cervical subluxation (HP:0003308) | 2.43033919 |
| 49 | Nemaline bodies (HP:0003798) | 2.39349392 |
| 50 | Lymphangioma (HP:0100764) | 2.35203686 |
| 51 | Abnormality of the ischium (HP:0003174) | 2.35161668 |
| 52 | Vertebral compression fractures (HP:0002953) | 2.34335541 |
| 53 | Hypoplasia of the iris (HP:0007676) | 2.33052067 |
| 54 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.30065039 |
| 55 | Osteolytic defects of the hand bones (HP:0009699) | 2.30065039 |
| 56 | Protrusio acetabuli (HP:0003179) | 2.29165200 |
| 57 | Ankle contracture (HP:0006466) | 2.26433351 |
| 58 | Dysmetric saccades (HP:0000641) | 2.26187217 |
| 59 | Aneurysm (HP:0002617) | 2.25242702 |
| 60 | Wide anterior fontanel (HP:0000260) | 2.21065871 |
| 61 | Shallow orbits (HP:0000586) | 2.20129694 |
| 62 | Premature rupture of membranes (HP:0001788) | 2.19914250 |
| 63 | Fragile skin (HP:0001030) | 2.18644987 |
| 64 | Round ear (HP:0100830) | 2.16679670 |
| 65 | Abnormality of dentin (HP:0010299) | 2.13545805 |
| 66 | Mitral valve prolapse (HP:0001634) | 2.13315286 |
| 67 | Hemiplegia (HP:0002301) | 2.12542560 |
| 68 | Hematochezia (HP:0002573) | 2.10210523 |
| 69 | Limited hip movement (HP:0008800) | 2.07765248 |
| 70 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.07705534 |
| 71 | Focal motor seizures (HP:0011153) | 2.06809677 |
| 72 | Left ventricular hypertrophy (HP:0001712) | 2.05615177 |
| 73 | Spinal rigidity (HP:0003306) | 2.04208456 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.03676747 |
| 75 | Scapular winging (HP:0003691) | 2.02495101 |
| 76 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.01629924 |
| 77 | Hyperextensible skin (HP:0000974) | 2.00907274 |
| 78 | Type 1 muscle fiber predominance (HP:0003803) | 1.99326194 |
| 79 | Ketoacidosis (HP:0001993) | 1.98437802 |
| 80 | Aortic aneurysm (HP:0004942) | 1.96709990 |
| 81 | Vascular tortuosity (HP:0004948) | 1.94447393 |
| 82 | Cardiovascular calcification (HP:0011915) | 1.94215586 |
| 83 | Overgrowth (HP:0001548) | 1.93899707 |
| 84 | Follicular hyperkeratosis (HP:0007502) | 1.92749225 |
| 85 | Cerebral hemorrhage (HP:0001342) | 1.92243457 |
| 86 | Blue sclerae (HP:0000592) | 1.91086334 |
| 87 | Visceral angiomatosis (HP:0100761) | 1.90746793 |
| 88 | Neck muscle weakness (HP:0000467) | 1.89821954 |
| 89 | Dilatation of the ascending aorta (HP:0005111) | 1.89535825 |
| 90 | Muscle stiffness (HP:0003552) | 1.88925377 |
| 91 | Hypoglycemic coma (HP:0001325) | 1.88762235 |
| 92 | Bradycardia (HP:0001662) | 1.88261478 |
| 93 | Pheochromocytoma (HP:0002666) | 1.87933837 |
| 94 | Arterial tortuosity (HP:0005116) | 1.87433860 |
| 95 | Striae distensae (HP:0001065) | 1.84644527 |
| 96 | Rapidly progressive (HP:0003678) | 1.84602107 |
| 97 | Spondylolisthesis (HP:0003302) | 1.84573403 |
| 98 | Vertebral arch anomaly (HP:0008438) | 1.84403213 |
| 99 | Muscular dystrophy (HP:0003560) | 1.83707235 |
| 100 | Ulnar bowing (HP:0003031) | 1.82394666 |
| 101 | Ulnar deviation of the wrist (HP:0003049) | 1.82169470 |
| 102 | Mitral regurgitation (HP:0001653) | 1.81394280 |
| 103 | Complement deficiency (HP:0004431) | 1.81296517 |
| 104 | Distal arthrogryposis (HP:0005684) | 1.81071312 |
| 105 | Bladder diverticulum (HP:0000015) | 1.80166314 |
| 106 | Joint laxity (HP:0001388) | 1.80035337 |
| 107 | Distal lower limb muscle weakness (HP:0009053) | 1.79110730 |
| 108 | Buphthalmos (HP:0000557) | 1.78441810 |
| 109 | Skin nodule (HP:0200036) | 1.78331630 |
| 110 | Hemangiomatosis (HP:0007461) | 1.77216921 |
| 111 | Coronal craniosynostosis (HP:0004440) | 1.76954250 |
| 112 | Aortic regurgitation (HP:0001659) | 1.76495095 |
| 113 | Hypoplastic left heart (HP:0004383) | 1.76435128 |
| 114 | Bronchomalacia (HP:0002780) | 1.75241728 |
| 115 | Wrist flexion contracture (HP:0001239) | 1.74771719 |
| 116 | Abnormality of the acetabulum (HP:0003170) | 1.72897123 |
| 117 | Deep venous thrombosis (HP:0002625) | 1.72394364 |
| 118 | Aortic dissection (HP:0002647) | 1.72252030 |
| 119 | Atonic seizures (HP:0010819) | 1.71971648 |
| 120 | Facial diplegia (HP:0001349) | 1.71605988 |
| 121 | Focal seizures (HP:0007359) | 1.71486294 |
| 122 | Hypoalphalipoproteinemia (HP:0003233) | 1.70950478 |
| 123 | Nephritis (HP:0000123) | 1.70818069 |
| 124 | Adactyly (HP:0009776) | 1.69347414 |
| 125 | Biconcave vertebral bodies (HP:0004586) | 1.69016602 |
| 126 | Hamartoma of the eye (HP:0010568) | 1.68677991 |
| 127 | Glomerulonephritis (HP:0000099) | 1.68408745 |
| 128 | Action tremor (HP:0002345) | 1.68113659 |
| 129 | Lower limb amyotrophy (HP:0007210) | 1.67659241 |
| 130 | Sudden cardiac death (HP:0001645) | 1.67622991 |
| 131 | Proximal amyotrophy (HP:0007126) | 1.67239543 |
| 132 | Cavernous hemangioma (HP:0001048) | 1.66431535 |
| 133 | Ectopia lentis (HP:0001083) | 1.65382993 |
| 134 | Hip contracture (HP:0003273) | 1.64803356 |
| 135 | Abnormal delivery (HP:0001787) | 1.63984966 |
| 136 | Peritonitis (HP:0002586) | 1.62761977 |
| 137 | Neurofibrillary tangles (HP:0002185) | 1.62347969 |
| 138 | Pulmonary artery stenosis (HP:0004415) | 1.62064280 |
| 139 | Distal lower limb amyotrophy (HP:0008944) | 1.60849005 |
| 140 | Aplasia involving bones of the extremities (HP:0009825) | 1.59879386 |
| 141 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.59879386 |
| 142 | Aplasia of the phalanges of the hand (HP:0009802) | 1.59879386 |
| 143 | Limb-girdle muscle atrophy (HP:0003797) | 1.58805008 |
| 144 | Rhabdomyolysis (HP:0003201) | 1.56746287 |
| 145 | Atrophic scars (HP:0001075) | 1.56104421 |
| 146 | Hypoglycemic seizures (HP:0002173) | 1.56047172 |
| 147 | Congestive heart failure (HP:0001635) | 1.54488271 |
| 148 | Venous abnormality (HP:0002624) | 1.53617757 |
| 149 | Short hallux (HP:0010109) | 1.52784727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TIE1 | 5.26734736 |
| 2 | TTN | 3.17226733 |
| 3 | LMTK2 | 2.74180483 |
| 4 | KDR | 2.65000290 |
| 5 | DMPK | 2.54065395 |
| 6 | RIPK1 | 2.50354424 |
| 7 | PHKG1 | 2.43665680 |
| 8 | PHKG2 | 2.43665680 |
| 9 | TRIB3 | 2.42859768 |
| 10 | MYLK | 2.11121897 |
| 11 | TGFBR2 | 2.01723365 |
| 12 | CAMK1G | 1.77673758 |
| 13 | MARK1 | 1.74150186 |
| 14 | INSRR | 1.70620982 |
| 15 | PDK4 | 1.69960048 |
| 16 | PDK3 | 1.69960048 |
| 17 | STK38L | 1.69934279 |
| 18 | OBSCN | 1.69629118 |
| 19 | NEK9 | 1.67176029 |
| 20 | PRKD3 | 1.66197267 |
| 21 | PKN2 | 1.61724236 |
| 22 | PAK3 | 1.52573846 |
| 23 | TRPM7 | 1.51603318 |
| 24 | PDGFRA | 1.50940064 |
| 25 | FER | 1.50633208 |
| 26 | CAMK1D | 1.50371148 |
| 27 | PTK2B | 1.47446337 |
| 28 | PDK2 | 1.42485070 |
| 29 | ICK | 1.39128436 |
| 30 | EPHB2 | 1.30475901 |
| 31 | FGFR2 | 1.30213198 |
| 32 | NTRK3 | 1.24922636 |
| 33 | PRKD1 | 1.24788530 |
| 34 | PIK3CA | 1.23609010 |
| 35 | PAK2 | 1.21555226 |
| 36 | MOS | 1.15099777 |
| 37 | MAP3K4 | 1.13026443 |
| 38 | FGFR4 | 1.11777887 |
| 39 | MAP3K6 | 1.11027109 |
| 40 | PIK3CG | 1.09846482 |
| 41 | DDR2 | 1.08246631 |
| 42 | PRKCH | 1.06812480 |
| 43 | PTK6 | 1.04302065 |
| 44 | WNK1 | 1.00810955 |
| 45 | SIK1 | 0.98393927 |
| 46 | PAK6 | 0.95900466 |
| 47 | EEF2K | 0.94548806 |
| 48 | ROCK1 | 0.93912915 |
| 49 | MAPK12 | 0.93811901 |
| 50 | WNK4 | 0.93099525 |
| 51 | PRKCE | 0.92654586 |
| 52 | CDC42BPA | 0.92136599 |
| 53 | NTRK1 | 0.90712084 |
| 54 | EPHA2 | 0.90207686 |
| 55 | EPHB1 | 0.88800201 |
| 56 | MTOR | 0.88597700 |
| 57 | CASK | 0.88198304 |
| 58 | PRKAA2 | 0.87321148 |
| 59 | STK38 | 0.83168845 |
| 60 | RET | 0.80647827 |
| 61 | LATS2 | 0.78775039 |
| 62 | PINK1 | 0.77153823 |
| 63 | CAMK2D | 0.76928019 |
| 64 | CAMKK2 | 0.76924554 |
| 65 | MAPK7 | 0.75605458 |
| 66 | PRKG2 | 0.75348368 |
| 67 | STK24 | 0.75113858 |
| 68 | PDGFRB | 0.74490806 |
| 69 | TESK1 | 0.74302475 |
| 70 | GRK7 | 0.73033891 |
| 71 | CAMK2B | 0.72438111 |
| 72 | CAMK4 | 0.72317199 |
| 73 | ERBB4 | 0.71953364 |
| 74 | MST1R | 0.71897228 |
| 75 | PRKAA1 | 0.71667393 |
| 76 | MAP2K4 | 0.71432134 |
| 77 | LATS1 | 0.70228270 |
| 78 | CAMK1 | 0.69553307 |
| 79 | CAMK2A | 0.68865948 |
| 80 | MARK2 | 0.68833131 |
| 81 | FGFR3 | 0.68570421 |
| 82 | PTK2 | 0.67978656 |
| 83 | NTRK2 | 0.66713307 |
| 84 | ROCK2 | 0.66554175 |
| 85 | MAP3K9 | 0.66241265 |
| 86 | RPS6KA2 | 0.64692501 |
| 87 | CAMKK1 | 0.64523560 |
| 88 | LIMK1 | 0.64070537 |
| 89 | MAP3K12 | 0.63464530 |
| 90 | TAOK1 | 0.62810831 |
| 91 | ILK | 0.62031441 |
| 92 | SGK3 | 0.61946933 |
| 93 | PDPK1 | 0.61902889 |
| 94 | MUSK | 0.60829874 |
| 95 | TGFBR1 | 0.60195496 |
| 96 | EPHA3 | 0.60097496 |
| 97 | ERN1 | 0.59812557 |
| 98 | TYRO3 | 0.59123570 |
| 99 | DAPK2 | 0.56268622 |
| 100 | BMX | 0.55977191 |
| 101 | SGK2 | 0.55652934 |
| 102 | MET | 0.55551410 |
| 103 | KSR2 | 0.55447522 |
| 104 | CDK5 | 0.54662128 |
| 105 | MAP3K7 | 0.54203986 |
| 106 | CAMK2G | 0.53414295 |
| 107 | GRK5 | 0.52474195 |
| 108 | AKT3 | 0.52242588 |
| 109 | MARK3 | 0.52007895 |
| 110 | MAP3K1 | 0.51767592 |
| 111 | MAPKAPK3 | 0.51048956 |
| 112 | CDK12 | 0.50796875 |
| 113 | MAP3K13 | 0.50013962 |
| 114 | SGK494 | 0.49296955 |
| 115 | SGK223 | 0.49296955 |
| 116 | PRKD2 | 0.49238729 |
| 117 | PRKG1 | 0.49204671 |
| 118 | MAP2K1 | 0.49162173 |
| 119 | MAP3K3 | 0.48845902 |
| 120 | FLT3 | 0.47846656 |
| 121 | MINK1 | 0.46447897 |
| 122 | STK11 | 0.44377374 |
| 123 | GSK3A | 0.44335685 |
| 124 | MAPK4 | 0.43027560 |
| 125 | SGK1 | 0.42294164 |
| 126 | IGF1R | 0.41844913 |
| 127 | EPHA4 | 0.41807297 |
| 128 | DAPK3 | 0.41361869 |
| 129 | SRC | 0.40822460 |
| 130 | PAK4 | 0.38623868 |
| 131 | PRKACB | 0.37687837 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.75873712 |
| 2 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.65342596 |
| 3 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.42645752 |
| 4 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.13213767 |
| 5 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.04793873 |
| 6 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.77520037 |
| 7 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.71763819 |
| 8 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.66457439 |
| 9 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.57995299 |
| 10 | Focal adhesion_Homo sapiens_hsa04510 | 1.49992565 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.49373068 |
| 12 | Insulin secretion_Homo sapiens_hsa04911 | 1.47464951 |
| 13 | GABAergic synapse_Homo sapiens_hsa04727 | 1.47321800 |
| 14 | Circadian entrainment_Homo sapiens_hsa04713 | 1.46934892 |
| 15 | Renin secretion_Homo sapiens_hsa04924 | 1.45445556 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.41937536 |
| 17 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.39967963 |
| 18 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.35694631 |
| 19 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.29707454 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.28683865 |
| 21 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.28476736 |
| 22 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.28319098 |
| 23 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.27957630 |
| 24 | Morphine addiction_Homo sapiens_hsa05032 | 1.23834914 |
| 25 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.21387112 |
| 26 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.20089480 |
| 27 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.17880175 |
| 28 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.15462167 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.13493633 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.12470133 |
| 31 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.11574614 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11553719 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.10832377 |
| 34 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.08632424 |
| 35 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08386210 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.07518921 |
| 37 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.06888922 |
| 38 | * Adherens junction_Homo sapiens_hsa04520 | 1.05834510 |
| 39 | Small cell lung cancer_Homo sapiens_hsa05222 | 1.05664765 |
| 40 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04078643 |
| 41 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.03525128 |
| 42 | Melanogenesis_Homo sapiens_hsa04916 | 1.03352602 |
| 43 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.02471324 |
| 44 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00403537 |
| 45 | Nicotine addiction_Homo sapiens_hsa05033 | 0.97856550 |
| 46 | Olfactory transduction_Homo sapiens_hsa04740 | 0.95807745 |
| 47 | Insulin resistance_Homo sapiens_hsa04931 | 0.94867766 |
| 48 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.94285172 |
| 49 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94166347 |
| 50 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.94087630 |
| 51 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.94014365 |
| 52 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.93959806 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 0.92925417 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.92745894 |
| 55 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.91574004 |
| 56 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.91010557 |
| 57 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.90886446 |
| 58 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.90451261 |
| 59 | Axon guidance_Homo sapiens_hsa04360 | 0.90412493 |
| 60 | Tight junction_Homo sapiens_hsa04530 | 0.89601064 |
| 61 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.89250954 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.88141564 |
| 63 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.88117460 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.87857316 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86060446 |
| 66 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.84882080 |
| 67 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.84662558 |
| 68 | Long-term depression_Homo sapiens_hsa04730 | 0.84281192 |
| 69 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.82284986 |
| 70 | Histidine metabolism_Homo sapiens_hsa00340 | 0.82202373 |
| 71 | Amoebiasis_Homo sapiens_hsa05146 | 0.81507293 |
| 72 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.81108786 |
| 73 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79175772 |
| 74 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.79070110 |
| 75 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78353057 |
| 76 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.78311739 |
| 77 | Cocaine addiction_Homo sapiens_hsa05030 | 0.77971279 |
| 78 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.75572508 |
| 79 | Alzheimers disease_Homo sapiens_hsa05010 | 0.74831552 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73965898 |
| 81 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.73771833 |
| 82 | ABC transporters_Homo sapiens_hsa02010 | 0.73561729 |
| 83 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73056356 |
| 84 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.72420510 |
| 85 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.71747225 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.70041881 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69209324 |
| 88 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.68848911 |
| 89 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.68838154 |
| 90 | Parkinsons disease_Homo sapiens_hsa05012 | 0.67148880 |
| 91 | Platelet activation_Homo sapiens_hsa04611 | 0.66661887 |
| 92 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.66153293 |
| 93 | Circadian rhythm_Homo sapiens_hsa04710 | 0.64894991 |
| 94 | Lysine degradation_Homo sapiens_hsa00310 | 0.64736906 |
| 95 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64659804 |
| 96 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.63905572 |
| 97 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.63692551 |
| 98 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.63526783 |
| 99 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.62942351 |
| 100 | Pathways in cancer_Homo sapiens_hsa05200 | 0.62037539 |
| 101 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.61285541 |
| 102 | Glioma_Homo sapiens_hsa05214 | 0.60846788 |
| 103 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.60352986 |
| 104 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.57967297 |
| 105 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.56708437 |
| 106 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.55412997 |
| 107 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.54879374 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.54220001 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.53630398 |
| 110 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.53056291 |
| 111 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52579076 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.52235993 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.51170135 |
| 114 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.51111660 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.50859773 |
| 116 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.50133381 |
| 117 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.48041895 |
| 118 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47664650 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46851388 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.46294874 |
| 121 | Melanoma_Homo sapiens_hsa05218 | 0.45781910 |

